vs

Side-by-side financial comparison of Ranpak Holdings Corp. (PACK) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 2.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 13.7%).

Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PACK vs PRCT — Head-to-Head

Bigger by revenue
PACK
PACK
1.1× larger
PACK
$93.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+17.9% gap
PRCT
20.2%
2.3%
PACK
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
13.7%
PACK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PACK
PACK
PRCT
PRCT
Revenue
$93.7M
$83.1M
Net Profit
$-31.6M
Gross Margin
39.0%
64.9%
Operating Margin
-1.0%
-4.1%
Net Margin
-38.1%
Revenue YoY
2.3%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.11
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACK
PACK
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$93.7M
$76.4M
Q3 25
$83.6M
$83.3M
Q2 25
$77.8M
$79.2M
Q1 25
$77.6M
$69.2M
Q4 24
$91.6M
$68.2M
Q3 24
$78.6M
$58.4M
Q2 24
$72.8M
$53.4M
Net Profit
PACK
PACK
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-10.4M
$-21.4M
Q2 25
$-7.5M
$-19.6M
Q1 25
$-10.9M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-8.1M
$-21.0M
Q2 24
$5.5M
$-25.6M
Gross Margin
PACK
PACK
PRCT
PRCT
Q1 26
64.9%
Q4 25
39.0%
60.6%
Q3 25
41.1%
64.8%
Q2 25
37.1%
65.4%
Q1 25
39.8%
63.9%
Q4 24
45.2%
64.0%
Q3 24
43.8%
63.2%
Q2 24
43.5%
59.0%
Operating Margin
PACK
PACK
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-1.0%
-40.6%
Q3 25
-6.8%
-27.8%
Q2 25
-12.5%
-28.0%
Q1 25
-10.3%
-39.7%
Q4 24
1.5%
-28.9%
Q3 24
-5.3%
-38.4%
Q2 24
-7.1%
-50.3%
Net Margin
PACK
PACK
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-12.4%
-25.7%
Q2 25
-9.6%
-24.7%
Q1 25
-14.0%
-35.8%
Q4 24
-27.6%
Q3 24
-10.3%
-35.9%
Q2 24
7.6%
-48.0%
EPS (diluted)
PACK
PACK
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.11
$-0.54
Q3 25
$-0.12
$-0.38
Q2 25
$-0.09
$-0.35
Q1 25
$-0.13
$-0.45
Q4 24
$-0.13
$-0.34
Q3 24
$-0.10
$-0.40
Q2 24
$0.07
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACK
PACK
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$63.0M
$245.6M
Total DebtLower is stronger
$401.9M
$51.7M
Stockholders' EquityBook value
$534.9M
$347.7M
Total Assets
$1.1B
$487.1M
Debt / EquityLower = less leverage
0.75×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACK
PACK
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$63.0M
$286.5M
Q3 25
$49.9M
$294.3M
Q2 25
$49.2M
$302.7M
Q1 25
$65.5M
$316.2M
Q4 24
$76.1M
$333.7M
Q3 24
$69.5M
$196.8M
Q2 24
$65.1M
$214.1M
Total Debt
PACK
PACK
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$401.9M
$51.6M
Q3 25
$403.1M
$51.6M
Q2 25
$403.1M
$51.5M
Q1 25
$405.2M
$51.5M
Q4 24
$406.4M
$51.5M
Q3 24
$403.2M
$51.4M
Q2 24
$396.1M
$51.4M
Stockholders' Equity
PACK
PACK
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$534.9M
$365.9M
Q3 25
$537.8M
$380.3M
Q2 25
$539.0M
$385.8M
Q1 25
$544.1M
$389.2M
Q4 24
$548.1M
$402.2M
Q3 24
$564.3M
$241.2M
Q2 24
$566.2M
$251.8M
Total Assets
PACK
PACK
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.1B
$508.1M
Q3 25
$1.1B
$511.5M
Q2 25
$1.1B
$513.1M
Q1 25
$1.1B
$519.4M
Q4 24
$1.1B
$534.0M
Q3 24
$1.1B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
PACK
PACK
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.75×
0.14×
Q3 25
0.75×
0.14×
Q2 25
0.75×
0.13×
Q1 25
0.74×
0.13×
Q4 24
0.74×
0.13×
Q3 24
0.71×
0.21×
Q2 24
0.70×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACK
PACK
PRCT
PRCT
Operating Cash FlowLast quarter
$19.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACK
PACK
PRCT
PRCT
Q1 26
Q4 25
$19.5M
$-10.3M
Q3 25
$8.5M
$-6.6M
Q2 25
$-3.6M
$-15.0M
Q1 25
$-1.3M
$-17.0M
Q4 24
$6.5M
$-32.4M
Q3 24
$10.1M
$-18.8M
Q2 24
$19.6M
$-15.7M
Free Cash Flow
PACK
PACK
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PACK
PACK
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PACK
PACK
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
PACK
PACK
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACK
PACK

Other$47.9M51%
Europe And Asia Segment$45.8M49%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons